未登录Multi-omic predictor of rapid and late relapse in primary triple negative breast cancer
Zhang, Y.; Nock, W.; Asad, S.; Adams, E.; Singh, J.; Damicis, A.; Lustberg, M. B.; Noonan, A.; Reinbolt, R.; Sardesai, S.; VanDeusen, J.; Wesolowski, R.; Williams, N.; Ramaswamy, B.; Stover, D. G. .png)
分享.png)
收藏Phase II study of gemcitabine, trastuzumab, and pertuzumab for HER2-positive metastatic breast cancer after prior pertuzumab-based therapyIyengar, N. M.; Smyth, L.; Lake, D.; Gucalp, A.; Singh, J.; Traina, T. A.; Defusco, P.; Dickler, M. N.; Fornier, M.; Goldfarb, S.; Jhaveri, K.; Latif, A.; Modi, S.; Troso-Sandoval, T.; Ulaner, G.; Jochelson, M.; Baselga, J.; Norton, L.; Hudis, C.; Dang, C. 分享 收藏 分享 收藏 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
